Finance ❯ Investment Strategies ❯ Risk Management

Legal Risks

Class Action Participation Securities Fraud Contingency Fees Class Action Risks Class Action Implications Securities Litigation Class Action Settlements Class Action Lawsuits Class Action Claims Investor Protection

Investors Urged To Join Phreesia Securities Suit as Lead-Plaintiff Deadline Nears

Firms are soliciting shareholders to seek lead-plaintiff status before a July 13, 2026 court deadline.

Securities Class Action Filed Against Zoetis Over Companion‑Animal Drug Claims

Pinterest Investors Urged to Seek Lead Role in Securities Suit Before May 29 Deadline

Law Firms Invite Lufax Investors to Seek Lead Plaintiff Role Before May 20 Deadline

Medpace Hit With Securities Class Action Over Book-to-Bill and Cancellation Claims

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Driven Brands Investor Lawsuits Expand as Firms Press May 8 Lead‑Plaintiff Deadline

Trip.com Investors Sought to Lead U.S. Securities Case as May 11 Deadline Nears

Law Firms Seek Lead Plaintiffs in Vital Farms ERP Disclosure Class Action

Law Firms Urge Corcept Investors To Seek Lead Plaintiff Role In Securities Suit Over Relacorilant

Law Firms Seek Ultragenyx Investors to Lead Securities Class Actions After OI Trial Miss

Corcept Investors Pressed to Seek Lead Role in Securities Suit After FDA Rebuff of Relacorilant

Ramaco Resources Investors Get March 31 Cut-Off To Seek Lead Role In Securities Case

Picard Medical Faces Securities Class Action Over Alleged Stock-Promotion Scheme

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

Trip.com Faces Federal Securities Class Action Over Alleged Antitrust Risk Omissions

Fermi IPO Lawsuits Set March 6 Lead Plaintiff Deadline in SDNY

Agilon Health Investors Urged to Seek Lead Role in Securities Suit Before March 2 Deadline

Fermi Faces Flurry of Securities Class Actions as Firms Vie for Lead Plaintiff Roles

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline